Angiotensin and the Heart

Softcover Nachdruck of the original 1. Auflage 1993
ISBN: 978-3-7985-0936-8
Verlag: Steinkopff

Buch, Englisch, 224 Seiten, Paperback, Format (B × H): 170 mm x 244 mm, Gewicht: 415 g

disease? Vogt, M., W. Matz, B. E. Strauer. 43 Myocardial Hypertrophy Molecular mechanisms of cardiac gene expression Nadal-Ginard, B., V. Mahdavi. 65 Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy Vatner, S. F., L. Hittinger.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Heusch, Gerd

Strauer, B. E.

Grobecker, H.

Inhaltsverzeichnis

Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.- Myocardial Perfusion.- Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone.- Local and neurohumoral control of coronary blood flow.- ACE-inhibitors in coronary artery disease?.- Myocardial Hypertrophy.- Molecular mechanisms of cardiac gene expression.- Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.- ACE-inhibitors and coronary microcirculation.- Ventricular Remodelling.- Myocardial fibrosis: role of angiotensin II and aldosterone.- Ventricular remodeling after myocardial infarction. Experimental and clinical studies.- Infarct Size, Reperfusion, Restenosis.- “Cardioprotection” by ACE-inhibitors in acute myocardial ischemia and infarction?.- Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.- Angiotensin-converting enzyme inhibitor in a human model of restenosis.- Heart failure.- Pathophysiology of heart failure and the renin-angiotensin-system.- Angiotensin-converting enzyme inhibitors in the treatment of clinical heart failure.- Summary and Perspectives.- A. Basic aspects.- B. Clinical aspects.